Golden
Sarsia Seed Management

Sarsia Seed Management

A venture capital and private equity firm investing in early-stage energy, clean technology, biotechnology, biotechnology, and life science companies.

Sarsia Seed Management is a venture capital and private equity firm investing in early-stage energy, clean technology, biotechnology, biotechnology, and life science companies that is headquartered in Bergen, Hordaland and was founded in 2006. According to the firms LinkedIn profile (as of December 2019), they have made 22 investments, have 14 companies in their portfolio, one IPO, and 5 exits. 



Investments

Notable investments made by Sarisa Seed Management include: Aquiloz, Delante, Xsens Flow Solutions, Nisonic, Trisense as, BerGenBio, Vaccibody, Apim Therapeutics, Avexxin, Prophylix, Sorbwater Technology, Pluvia, Sono Clear, Heimdall Power, Med-Storm Innovation, SeaFarm Solutions, Sea-Hawk, Windsim, ScreenCancer, and Blue Limit. 

Investment funds

Sarisa Seed Fund I

The Sarisa Seed Fund I was established in 2006 with $50 million in funding. The fund focused on investing in energy, technology, biotechnology, life science, and marine technology companies. The fund made 22 investments and 9 exits. 

Sarisa Seed Fund II

The Sarisa Seed Fund II was established in 2017 with $55 million in funding for investing in energy, technology, biotechnology, and life science companies. The firm plans on using their Sarisa Seed Fund II for making approximately 15-20 investments. 

Timeline

Funded Companies

1 Result
Company
Company
Website
Website
Industry
Industry
Location
Location

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References